Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-10

Clinical Trial Update: Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis [NA]

View source ↗

Summary

The document describes an ongoing clinical trial evaluating the efficacy and safety of ganciclovir capsules for refractory moderate-to-severe allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganciclovir capsules (ganciclovir)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Rhinitis, Allergic | NA | Status: RECRUITING